Sr. Director, Head of Mid-Sized , Europe

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs.

At Acadia, we’re here to be their difference.

The Sr Director, Head of Mid-Size Countries (MSC) position will play a pivotal role in establishing our presence (fit for purpose) in MSCs where we intend to launch and ensure successful launch of our product (and any follow-on products) in those markets. In addition, this person will also be responsible for selecting, on-boarding and managing Distributor partners that will launch Acadia’s products in selected EU countries where Acadia will not operate directly.

Reporting directly to the SVP, GM of Europe, this position will be responsible for overseeing all aspects of the operations and driving commercial success in those markets.

• Strategic Planning:
  Develop, collaborate on, and implement strategic cross-functional plans for launching and commercializing the rare disease drug in selected MSCs, ensuring alignment with overall company objectives, global brand strategy, allocated resources and market dynamics.
• Market Entry Strategy:
  Identify target segments within the MSC markets and develop comprehensive market entry strategies, considering regulatory requirements, reimbursement landscape, competitive landscape, and patient access pathways. Develop market access strategy with the support of Regional Market Access as well as local market access vendors. Successfully drive access and reimbursement.
• Cross-Functional Leadership:
  Collaborate closely with cross-functional teams including Marketing, Sales, Medical Affairs & Patient Advocacy, Market Access, Regulatory Affairs, and Supply Chain to execute launch plans effectively and achieve business objectives.
• Stakeholder Engagement:
  In close collaboration with Medical Affairs build and maintain strong external networks and relationships with key stakeholders including healthcare professionals, patient advocacy groups, regulatory agencies, and payers in the selected MSC markets to drive awareness, education, and access to the rare disease drugs. In alignment with the Government Affairs and Market Access, report on relevant developments in health policy initiatives in MSC markets and design & implement relevant stakeholder engagement/initiatives plan
• Team Leadership:
  Recruit, develop, and manage a high-performing team of professionals to support the MSC countries’ operations, providing leadership, guidance, and mentorship to ensure team success.
• Selection and onboarding of distributor partners for certain European markets
• Financial Management:
  Develop and manage the cross-functional cluster P&L incl. of budgets, forecasts, and financial targets for the MSC operations, ensuring optimal allocation of approved resources and delivering on financial goals.
• Compliance and Ethics:
  Ensure compliance with all relevant laws, regulations, and company policies in the respective MSC countries, maintaining the highest standards of ethics and integrity in all business activities.

Advanced degree in a Life Science, pharma, biotech, Business Administration or other related area. Targeting 15 years of progressive experience in the pharmaceutical industry, with at least 5 years of experience in a leadership role overseeing commercial operations above the country level. Fluent in English and preferably at least one local (MSC) languages. An equivalent combination of relevant education and experience may be considered.

• Proven track record of successfully launching and commercializing pharmaceutical products in MSC markets, preferably in the…